Bmi1 overexpression in MSCs can stimulate MSC proliferation and differentiation into osteoblasts by inactivating p16/p19 signaling and inhibiting oxidative stress, thereby enhancing osteoblast bone formation and exerting anti-osteoporosis effects (142). The gene discussed is CDKN2A; the disease is osteoporosis.